Título:
|
Longitudinal assessment of high versus low levels of fractional exhaled nitric oxide among children with asthma and atopy
|
Autores:
|
Elmasri, M. ;
Romero, K.M. ;
Gilman, R.H. ;
Hansel, N.N. ;
Robinson, C.L. ;
Baumann, L.M. ;
Cabrera, L. ;
Hamilton, R.G. ;
Checkley, W. ;
Combe, J. ;
Gómez, A. ;
Gonzalvez, G. ;
Barnes, K. ;
Wise, R. ;
Breysse, P. ;
Williams, D.
|
Tipo de documento:
|
texto impreso
|
Editorial:
|
Springer Verlag, 2020-06-10T18:12:13Z
|
Nota general:
|
info:eu-repo/semantics/restrictedAccess
https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
|
Idiomas:
|
Inglés
|
Palabras clave:
|
Editados por otras instituciones
,
Artículos
,
Artículos en revistas indizadas
|
Resumen:
|
Purpose: Fractional exhaled nitric oxide (FeNO) has emerged as an important biomarker in asthma. Increasing evidence points to atopy as a confounding factor in the interpretation of elevated FeNO. We conducted a longitudinal study to understand the clinical significance of FeNO as an inflammatory biomarker. Methods: We identified 19 children aged 13-15 years at baseline with a significant elevation in FeNO ? 80 parts per billion (ppb) and randomly selected a group of children of similar age with a moderate elevation (40-79 ppb) and normal-to-low FeNO (
|
En línea:
|
http://doi.org/10.1007/s00408-013-9551-8
|